Synergistic antiviral activity against human adenovirus through combination of itraconazole and brincidofovir.
Saved in:
| Title: | Synergistic antiviral activity against human adenovirus through combination of itraconazole and brincidofovir. |
|---|---|
| Authors: | Zamzamy M; Research Department Virus Immunology, Leibniz Institute of Virology, Hamburg, Germany., Post S; Research Department Virus Immunology, Leibniz Institute of Virology, Hamburg, Germany., Ip WH; Research Department Viral Transformation, Leibniz Institute of Virology, Hamburg, Germany., Hahlin E; Research Department of Clinical Microbiology, Umeå University, Umeå, Sweden.; Umeå Centre for Microbial Research (UCMR), Umeå University, Umeå, Sweden.; Molecular Infection Biology Sweden (MIMS), Umeå University, Umeå, Sweden.; Science for Life Laboratory (SciLifeLab), Umeå University, Umeå, Sweden., Kühn S; Technology Platform Microscopy and Image Analysis, Leibniz Institute of Virology, Hamburg, Germany., Pirosu A; Research Department Virus Immunology, Leibniz Institute of Virology, Hamburg, Germany., Conze C; Technology Platform Microscopy and Image Analysis, Leibniz Institute of Virology, Hamburg, Germany., Baumdick M; Research Department Virus Immunology, Leibniz Institute of Virology, Hamburg, Germany.; Division for Regenerative Medicine and Immunology, III. Department of Medicine, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany., Bunders MJ; Research Department Virus Immunology, Leibniz Institute of Virology, Hamburg, Germany.; Division for Regenerative Medicine and Immunology, III. Department of Medicine, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany., Zecher BF; Research Department Virus Immunology, Leibniz Institute of Virology, Hamburg, Germany.; I. Department of Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany., Hoelzemer A; I. Department of Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.; Institute for Infection Research and Vaccine Development (IIRVD), University Medical Centre Hamburg-Eppendorf, Hamburg, Germany., Linder S; Institute for Medical Microbiology, Virology and Hygiene, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany., Arnberg N; Research Department of Clinical Microbiology, Umeå University, Umeå, Sweden.; Umeå Centre for Microbial Research (UCMR), Umeå University, Umeå, Sweden.; Molecular Infection Biology Sweden (MIMS), Umeå University, Umeå, Sweden.; Science for Life Laboratory (SciLifeLab), Umeå University, Umeå, Sweden., Dobner T; Research Department Viral Transformation, Leibniz Institute of Virology, Hamburg, Germany., Altfeld M; Research Department Virus Immunology, Leibniz Institute of Virology, Hamburg, Germany., Schloer S; Research Department Virus Immunology, Leibniz Institute of Virology, Hamburg, Germany.; Institute of Immunology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany. |
| Source: | British journal of pharmacology [Br J Pharmacol] 2026 Apr; Vol. 183 (7), pp. 1578-1601. Date of Electronic Publication: 2025 Nov 28. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley Country of Publication: England NLM ID: 7502536 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5381 (Electronic) Linking ISSN: 00071188 NLM ISO Abbreviation: Br J Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41314647 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Synergistic antiviral activity against human adenovirus through combination of itraconazole and brincidofovir. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Zamzamy+M%22">Zamzamy M</searchLink>; Research Department Virus Immunology, Leibniz Institute of Virology, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Post+S%22">Post S</searchLink>; Research Department Virus Immunology, Leibniz Institute of Virology, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Ip+WH%22">Ip WH</searchLink>; Research Department Viral Transformation, Leibniz Institute of Virology, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Hahlin+E%22">Hahlin E</searchLink>; Research Department of Clinical Microbiology, Umeå University, Umeå, Sweden.; Umeå Centre for Microbial Research (UCMR), Umeå University, Umeå, Sweden.; Molecular Infection Biology Sweden (MIMS), Umeå University, Umeå, Sweden.; Science for Life Laboratory (SciLifeLab), Umeå University, Umeå, Sweden.<br /><searchLink fieldCode="AU" term="%22Kühn+S%22">Kühn S</searchLink>; Technology Platform Microscopy and Image Analysis, Leibniz Institute of Virology, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Pirosu+A%22">Pirosu A</searchLink>; Research Department Virus Immunology, Leibniz Institute of Virology, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Conze+C%22">Conze C</searchLink>; Technology Platform Microscopy and Image Analysis, Leibniz Institute of Virology, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Baumdick+M%22">Baumdick M</searchLink>; Research Department Virus Immunology, Leibniz Institute of Virology, Hamburg, Germany.; Division for Regenerative Medicine and Immunology, III. Department of Medicine, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Bunders+MJ%22">Bunders MJ</searchLink>; Research Department Virus Immunology, Leibniz Institute of Virology, Hamburg, Germany.; Division for Regenerative Medicine and Immunology, III. Department of Medicine, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Zecher+BF%22">Zecher BF</searchLink>; Research Department Virus Immunology, Leibniz Institute of Virology, Hamburg, Germany.; I. Department of Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Hoelzemer+A%22">Hoelzemer A</searchLink>; I. Department of Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.; Institute for Infection Research and Vaccine Development (IIRVD), University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Linder+S%22">Linder S</searchLink>; Institute for Medical Microbiology, Virology and Hygiene, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Arnberg+N%22">Arnberg N</searchLink>; Research Department of Clinical Microbiology, Umeå University, Umeå, Sweden.; Umeå Centre for Microbial Research (UCMR), Umeå University, Umeå, Sweden.; Molecular Infection Biology Sweden (MIMS), Umeå University, Umeå, Sweden.; Science for Life Laboratory (SciLifeLab), Umeå University, Umeå, Sweden.<br /><searchLink fieldCode="AU" term="%22Dobner+T%22">Dobner T</searchLink>; Research Department Viral Transformation, Leibniz Institute of Virology, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Altfeld+M%22">Altfeld M</searchLink>; Research Department Virus Immunology, Leibniz Institute of Virology, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Schloer+S%22">Schloer S</searchLink>; Research Department Virus Immunology, Leibniz Institute of Virology, Hamburg, Germany.; Institute of Immunology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227502536%22">British journal of pharmacology</searchLink> [Br J Pharmacol] 2026 Apr; Vol. 183 (7), pp. 1578-1601. <i>Date of Electronic Publication: </i>2025 Nov 28. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>7502536 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1476-5381 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200071188%22">00071188 </searchLink><i>NLM ISO Abbreviation: </i>Br J Pharmacol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41314647 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/bph.70258 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1578 Titles: – TitleFull: Synergistic antiviral activity against human adenovirus through combination of itraconazole and brincidofovir. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Zamzamy M – PersonEntity: Name: NameFull: Post S – PersonEntity: Name: NameFull: Ip WH – PersonEntity: Name: NameFull: Hahlin E – PersonEntity: Name: NameFull: Kühn S – PersonEntity: Name: NameFull: Pirosu A – PersonEntity: Name: NameFull: Conze C – PersonEntity: Name: NameFull: Baumdick M – PersonEntity: Name: NameFull: Bunders MJ – PersonEntity: Name: NameFull: Zecher BF – PersonEntity: Name: NameFull: Hoelzemer A – PersonEntity: Name: NameFull: Linder S – PersonEntity: Name: NameFull: Arnberg N – PersonEntity: Name: NameFull: Dobner T – PersonEntity: Name: NameFull: Altfeld M – PersonEntity: Name: NameFull: Schloer S IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: 2026 Apr Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1476-5381 Numbering: – Type: volume Value: 183 – Type: issue Value: 7 Titles: – TitleFull: British journal of pharmacology Type: main |
| ResultId | 1 |